MC
COCH icon

Meteora Capital’s Envoy Medical COCH Stock Holding History

Meteora Capital’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7K Hold
28,051
– – ﹤0.01% 297
2025
Q4 		$18.5K Buy
28,051
+681
+2% +$539 ﹤0.01% 284
2025
Q3 		$21.2K Buy
+27,370
New +$37.1K ﹤0.01% 238
2024
Q1 		– Sell
-425,606
Closed -$771K – 280
2023
Q4 		$771K Hold
425,606
– – 0.13% 132
2023
Q3 		$2.99M Buy
425,606
+140,822
+49% +$1.41M 0.51% 54
2023
Q2 		$2.92M Sell
284,784
-120,000
-30% -$1.21M 0.54% 57
2023
Q1 		$4.07M Buy
+404,784
New +$4.06M 0.48% 65

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Meteora Capital's COCH Position: Q1 2026 in Review

Meteora Capital held its Envoy Medical (COCH) position steady in Q1 2026 at 28,051 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Meteora Capital first reported a position in COCH in Q1 2023 and has held it in 7 quarters since. The position peaked at $4.07M in Q1 2023. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Meteora Capital held 28,051 shares of Envoy Medical worth $18.7K as of Q1 2026.
  • Meteora Capital left its Envoy Medical share count unchanged in Q1 2026.
  • Envoy Medical made up ﹤0.01% of Meteora Capital's portfolio in Q1 2026, its #297 holding.
  • Meteora Capital first reported a position in Envoy Medical in Q1 2023 and has held it in 7 quarters since.
  • Meteora Capital's Envoy Medical position peaked at $4.07M in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.